How fall vaccines keep pace with evolving viruses
Drs. Manish Sadarangani and Julie Bettinger share how new vaccines are handled to ensure they are safe and effective against evolving strains of influenza and SARS-CoV-2.
Drug discovery at an atomic scale
UBC’s Dr. Sriram Subramaniam is using powerful cryo-electron microscopes to accelerate drug development for cancer, infectious diseases and more.
New variants, new vaccines. Here’s what you should know about COVID-19 going into fall.
UBC infectious disease expert Dr. Horacio Bach answers key questions about new COVID-19 variants and vaccines.
UBC’s contributions to combatting COVID-19
Look back at some of the UBC Faculty of Medicine’s efforts that contributed to our ongoing pandemic response and recovery.
Launching Canada’s Immuno-Engineering and Biomanufacturing Hub
Leaders from across B.C.’s biotech sector gathered to launch a new national research hub led by UBC.
From COVID-19 to the common cold: UBC scientists identify broadly-effective, infection-halting compound
The findings reveal a potential path toward antiviral treatments that could be used against multiple types of coronaviruses.
Strengthening pathogen research in British Columbia
New federal funding supports UBC researchers studying infectious diseases at the BCCDC Public Health Laboratory.
Bivalent vaccines are here – what it means for people who are pregnant
Dr. Deborah Money answers common questions that expecting parents have about vaccinations this fall.
UBC faculty of medicine researchers receive federal support to advance mRNA vaccine technologies
$11.1 million will improve the delivery and efficacy of mRNA vaccines and boost B.C. biotechnology impact on the global stage.
COVID-19 lockdown may have accelerated HIV transmission in some at-risk populations
A new UBC study sheds light on how COVID-19 pandemic restrictions impacted another public health threat — HIV.